Literature DB >> 1707470

Replacement of donor lymphoid tissue in small-bowel transplants.

Y Iwaki1, T E Starzl, A Yagihashi, S Taniwaki, K Abu-Elmagd, A Tzakis, J Fung, S Todo.   

Abstract

The presence of recipient lymphocytes in grafts is thought to equate with rejection. Thus, we wished to follow the fate of lymphocytes after transplant of the small bowel. Three complete small-bowel transplants, two with the liver from the same donor also transplanted, were done successfully. Patients were immunosuppressed with FK 506. 5 to 11% of lymphocytes in the recipients' peripheral blood were of donor origin during the early postoperative period when there were no clinical signs of graft-versus-host disease. However, donor cells were no longer detectable after 12 to 54 days. Serial biopsy specimens of the grafted small bowel showed progressive replacement of lymphocytes in the lamina propria by those of the recipient's HLA phenotype. Lymphoid repopulation was complete after 10 to 12 weeks but the epithelial cells of the intestine remained those of the donor. The patients are on enteral alimentation after 5, 6, and 8 months with histopathologically normal or nearly normal intestines. Re-examination of assumptions about the rejection of intestinal grafts and strategies for its prevention are required following these observations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1707470      PMCID: PMC2983478          DOI: 10.1016/0140-6736(91)92517-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

1.  Homotransplantation of multiple visceral organs.

Authors:  T E STARZL; H A KAUPP; D R BROCK; G W BUTZ; J W LINMAN
Journal:  Am J Surg       Date:  1962-02       Impact factor: 2.565

2.  Lymphocyte infiltration patterns in rat small-bowel transplants.

Authors:  C L Clark; A J Cunningham; P W Crane; R F Wood; P A Lear
Journal:  Transplant Proc       Date:  1990-12       Impact factor: 1.066

3.  Use of FK 506 in pediatric patients.

Authors:  A G Tzakis; J J Fung; S Todo; J Reyes; M Green; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

4.  Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506.

Authors:  N Murase; A J Demetris; T Matsuzaki; A Yagihashi; S Todo; J Fung; T E Starzl
Journal:  Surgery       Date:  1991-07       Impact factor: 3.982

5.  Transplantation of small bowel in the rat: technical and immunological considerations.

Authors:  G J Monchik; P S Russell
Journal:  Surgery       Date:  1971-11       Impact factor: 3.982

6.  Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506.

Authors:  P M Markus; X Cai; W Ming; A J Demetris; J J Fung; T E Starzl
Journal:  Transplantation       Date:  1991-10       Impact factor: 4.939

7.  Origin of lymph node-derived lymphocytes in human hepatic allografts.

Authors:  John J Fung; Adriane Zeevi; A Jake Demetris; Thomas E Starzl; Bernd Markus; Kangnian Chen; Marilyn Marrarri; Rene J Duquesnoy
Journal:  Clin Transpl       Date:  1989

8.  Expression of major histocompatibility complex antigens and replacement of donor cells by recipient ones in human liver grafts.

Authors:  A S Gouw; H J Houthoff; S Huitema; J M Beelen; C H Gips; S Poppema
Journal:  Transplantation       Date:  1987-02       Impact factor: 4.939

9.  Interactions between bronchoalveolar lymphocytes and macrophages in heart-lung transplant recipients.

Authors:  J J Fung; A Zeevi; C Kaufman; I L Paradis; J H Dauber; R L Hardesty; B Griffith; R J Duquesnoy
Journal:  Hum Immunol       Date:  1985-11       Impact factor: 2.850

10.  Successful small-bowel/liver transplantation.

Authors:  D Grant; W Wall; R Mimeault; R Zhong; C Ghent; B Garcia; C Stiller; J Duff
Journal:  Lancet       Date:  1990-01-27       Impact factor: 79.321

  10 in total
  56 in total

1.  The birth of clinical organ transplantation.

Authors:  T E Starzl
Journal:  J Am Coll Surg       Date:  2001-04       Impact factor: 6.113

Review 2.  Regulation of immune reactivity and tolerance by antigen migration and localization: with particular reference to allo- and xenotransplantation.

Authors:  T E Starzl; N Murase; A W Thomson; M Trucco; A Rao
Journal:  Transplant Proc       Date:  1999-06       Impact factor: 1.066

Review 3.  Immunity and tolerance are related, and governed by antigen migration and localization.

Authors:  T E Starzl; N Murase; A W Thomson; M Trucco; A Rao
Journal:  Transplant Proc       Date:  1999 Feb-Mar       Impact factor: 1.066

Review 4.  Transplantation tolerance, microchimerism, and the two-way paradigm.

Authors:  T E Starzl; A J Demetris
Journal:  Theor Med Bioeth       Date:  1998-09

5.  Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: with particular emphasis on donor major histocompatibility complex class II+ cells.

Authors:  Toyokazu Okuda; Takashi Ishikawa; Olga Azhipa; Naoya Ichikawa; Anthony J Demetris; Thomas E Starzl; Noriko Murase
Journal:  Transplantation       Date:  2002-07-15       Impact factor: 4.939

6.  Management of intestinal transplantation in humans.

Authors:  K Abu-Elmagd; J J Fung; J Reyes; A Casavilla; D H Van Thiel; Y Iwaki; V Warty; N Nikolaidis; J Block; K Nakamura
Journal:  Transplant Proc       Date:  1992-06       Impact factor: 1.066

Review 7.  Cell migration, chimerism, and graft acceptance.

Authors:  T E Starzl; A J Demetris; N Murase; S Ildstad; C Ricordi; M Trucco
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

Review 8.  Recent progress in intestinal transplantation.

Authors:  C I Clark
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

Review 9.  Mixed chimerism and split tolerance: mechanisms and clinical correlations.

Authors:  David P Al-Adra; Colin C Anderson
Journal:  Chimerism       Date:  2011 Oct-Dec

10.  In situ proliferating status of mononuclear cells in rat small bowel grafts.

Authors:  M Okamoto; K Arakawa; S Fushiki
Journal:  Int J Exp Pathol       Date:  1995-08       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.